Medical
First Australian study on cardiovascular impact of COVID-19 at The Alfred
Medical News: While some international evidence suggests the infectious virus can leave behind cardiac scarring, cardiologists and respiratory physicians are working together to explore whether unexplained breathlessness may be the first sign of trouble.
The Alfred’s director of cardiology Professor David Kaye, and cardiologist Dr Shane Nanayakkara, have spent years studying pressure levels inside the hearts of patients as part of research into a condition known as heart failure with preserved ejection fraction (HFpEF).
In HFpEF, the heart muscle becomes stiff and doesn’t fill properly, leading to increased pressure and shortness of breath. Together with respiratory physician Professor Trevor Williams, Professor Kaye and his team are looking for the same signs of damage in those who have had COVID-19.
“While the international evidence has been mixed, it’s possible that some patients sustain cardiac damage from COVID-19 infection,” Prof Kaye said.
“Similar to HFpEF, one of the ways of we can measure changes in the heart is to perform catheter testing during exercise.”
After inserting a slim catheter into the body via a patient’s arm, they are asked to lie on a bed that has bike pedals attached. Dr Nanayakkara said the team then observes the pressures inside the heart as the patient exercises.
“If the pressures go up abnormally, that’s a warning sign, and then we can explore further and, hopefully, offer treatment,” Dr Nanayakkara said.
“We still have a lot to learn about the mark COVID can leave on the heart, but we encourage anyone who experiences unexplained and prolonged breathlessness after the virus to ask their GP for a referral to come and see us in the Heart Centre at The Alfred.”
News & Trends - MedTech & Diagnostics
$54 million cancer centre opens in one of Australia’s fastest growing communities
MedTech & Diagnostics News: Cancer care provider, GenesisCare, is now treating patients at a new $54 million integrated cancer centre […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreNews & Trends - MedTech & Diagnostics
Queensland elevates diagnostic precision with cutting-edge imaging technology
MedTech & Diagnostics News: Mackay Base Hospital and Qscan Mackay have unveiled state-of-the-art medical imaging machines to elevate patient care […]
MoreNews & Trends - Pharmaceuticals
Landmark collaboration sparks inauguration of precision care clinic
Pharma News: In a landmark collaboration, Australians with cancer will receive more personalised care through the newly established Precision Care […]
More